Literature DB >> 27758056

Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing is Context Dependent.

Anthony J Burand1,2, Oliver W Gramlich3, Alex J Brown1,2, James A Ankrum2.   

Abstract

Tailoring MSCs to fit the disease. Fresh, cryopreserved and, prelicensed cryopreserved MSC are all being explored to treat numerous diseases, but all are not suitable to treat all conditions. injury. "*" denotes preferred therapeutic strategy when both fresh MSC and cryo-MSC have shown utility in treating the disease but one is more efficacious or logistically suitable. ABBREVIATIONS: CLI, critical limb ischemia; GvHD. graft versus host disease; I/R, ischemia reperfusion (I/R); OI, osteogenesis imperfecta.
© 2016 AlphaMed Press.

Entities:  

Keywords:  Cell transplantation; Immunosuppression; Indoleamine 2,3 dioxygenase; Mesenchymal stem cells; Retina

Mesh：

Substances：

Year:  2016        PMID： 27758056      PMCID： PMC5397371          DOI： 10.1002/stem.2528

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


  19 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

Review 2.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

Review 3.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

4.  Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.

Authors:  Fernanda F Cruz; Zachary D Borg; Meagan Goodwin; Dino Sokocevic; Darcy Wagner; David H McKenna; Patricia R M Rocco; Daniel J Weiss
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

5.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

6.  Genomic and functional comparison of mesenchymal stromal cells prepared using two isolation methods.

Authors:  Satoru Otsuru; Ted J Hofmann; Pichai Raman; Timothy S Olson; Adam J Guess; Massimo Dominici; Edwin M Horwitz
Journal:  Cytotherapy       Date:  2015-03       Impact factor: 5.414

7.  Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Authors:  Guangwen Ren; Juanjuan Su; Liying Zhang; Xin Zhao; Weifang Ling; Andrew L'huillie; Jimin Zhang; Yongqing Lu; Arthur I Roberts; Weizhi Ji; Huatang Zhang; Arnold B Rabson; Yufang Shi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

8.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.

Authors:  Moïra François; Ian B Copland; Shala Yuan; Raphaëlle Romieu-Mourez; Edmund K Waller; Jacques Galipeau
Journal:  Cytotherapy       Date:  2011-10-27       Impact factor: 5.414

9.  Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis.

Authors:  Morgana T L Castelo-Branco; Igor D P Soares; Daiana V Lopes; Fernanda Buongusto; Cesonia A Martinusso; Alyson do Rosario; Sergio A L Souza; Bianca Gutfilen; Lea Mirian B Fonseca; Celeste Elia; Kalil Madi; Alberto Schanaider; Maria Isabel D Rossi; Heitor S P Souza
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo.

Authors:  Raghavan Chinnadurai; Marco A Garcia; Yumiko Sakurai; Wilbur A Lam; Allan D Kirk; Jacques Galipeau; Ian B Copland
Journal:  Stem Cell Reports       Date:  2014-06-06       Impact factor: 7.765
View more
  17 in total

Review 1.  Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics.

Authors:  David A Castilla-Casadiego; Ana M Reyes-Ramos; Maribella Domenech; Jorge Almodovar
Journal:  Ann Biomed Eng       Date:  2019-11-08       Impact factor: 3.934

2.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Authors:  Raghavan Chinnadurai; Devi Rajan; Muna Qayed; Dalia Arafat; Marco Garcia; Yifei Liu; Subra Kugathasan; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

Review 3.  Manufacturing of primed mesenchymal stromal cells for therapy.

Authors:  James Q Yin; Jun Zhu; James A Ankrum
Journal:  Nat Biomed Eng       Date:  2019-01-28       Impact factor: 25.671

4.  Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome.

Authors:  Raghavan Chinnadurai; Matthew H Forsberg; John A Kink; Peiman Hematti; Christian M Capitini
Journal:  Curr Stem Cell Rep       Date:  2020-08-08

5.  Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration.

Authors:  Pengfei Chen; Lin Zheng; Yiyun Wang; Min Tao; Ziang Xie; Chen Xia; Chenhui Gu; Jiaxin Chen; Pengcheng Qiu; Sheng Mei; Lei Ning; Yiling Shi; Chen Fang; Shunwu Fan; Xianfeng Lin
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

Review 6.  Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.

Authors:  Nádia de Cássia Noronha; Amanda Mizukami; Carolina Caliári-Oliveira; Juçara Gastaldi Cominal; José Lucas M Rocha; Dimas Tadeu Covas; Kamilla Swiech; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2019-05-02       Impact factor: 6.832

7.  Dose and duration of interferon γ pre-licensing interact with donor characteristics to influence the expression and function of indoleamine-2,3-dioxygenase in mesenchymal stromal cells.

Authors:  Devlin T Boyt; Lauren K Boland; Anthony J Burand; Alex J Brown; James A Ankrum
Journal:  J R Soc Interface       Date:  2020-06-17       Impact factor: 4.118

8.  Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells.

Authors:  Anthony J Burand; Lin Di; Lauren K Boland; Devlin T Boyt; Michael V Schrodt; Donna A Santillan; James A Ankrum
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

Review 9.  Recent advances in understanding mesenchymal stromal cells.

Authors:  Erika Rendra; Eleonora Scaccia; Karen Bieback
Journal:  F1000Res       Date:  2020-02-27

Review 10.  Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders.

Authors:  Lydia J Beeken; Darren S J Ting; Laura E Sidney
Journal:  Stem Cells Transl Med       Date:  2020-09-08       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.